Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2013

01-03-2013 | Review

Eosinophilic Esophagitis: Current Treatment

Authors: Matthew Redd, Ron Schey

Published in: Digestive Diseases and Sciences | Issue 3/2013

Login to get access

Abstract

Eosinophilic esophagitis (EoE) is a relatively new entity with a significant amount of increased recognition over the last decade. The mainstay treatments of EoE are designed to eliminate the causative allergens or to reduce their effects on the esophageal mucosa. Common treatments include dietary modification, proton pump inhibitors, systemic and topical corticosteroids, and endoscopic treatments. As the pathogenesis of EoE is explored, new and novel treatments are being studied that target specific pathways and chemokines identified in as precipitating agents of EoE. This is a rapidly evolving field with significant ongoing research and clinical studies. Our review will therefore focus on current and novel treatment approaches to the disease.
Literature
1.
go back to reference Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978;74:1298–1301.PubMed Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978;74:1298–1301.PubMed
2.
go back to reference Furuta GT, Liacouras CA, Clooins MH, et al. First International Gastrointestinal Eosinophil Research Symposium (FIGERS) subcommittees: eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.PubMedCrossRef Furuta GT, Liacouras CA, Clooins MH, et al. First International Gastrointestinal Eosinophil Research Symposium (FIGERS) subcommittees: eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.PubMedCrossRef
3.
go back to reference Liacouras C. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr. 2003;27:S23–S28.CrossRef Liacouras C. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr. 2003;27:S23–S28.CrossRef
4.
go back to reference Sorser SA, Barawi M, Hagglund K, Almojaned M, Lyons H. Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation. J Gastroenterol. 2012 [Epub ahead of print]. Sorser SA, Barawi M, Hagglund K, Almojaned M, Lyons H. Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation. J Gastroenterol. 2012 [Epub ahead of print].
5.
6.
go back to reference Shi YN, Sun SJ, Xiong LS, Cao QH, Cui Y, Chen MH. Prevelence, clinical manifestations and endoscopic features of eosinophilic esophagitis: a pathological review in China. J Dig Dis. 2012;13:304–309.PubMedCrossRef Shi YN, Sun SJ, Xiong LS, Cao QH, Cui Y, Chen MH. Prevelence, clinical manifestations and endoscopic features of eosinophilic esophagitis: a pathological review in China. J Dig Dis. 2012;13:304–309.PubMedCrossRef
7.
go back to reference Mackenzie SH, Go M, Chadwick B, et al. Eosinophilic eosophagitis in patients presenting with dysphagia—a prospective analysis. Aliment Pharmacol Ther. 2008;28:1140–1146.PubMedCrossRef Mackenzie SH, Go M, Chadwick B, et al. Eosinophilic eosophagitis in patients presenting with dysphagia—a prospective analysis. Aliment Pharmacol Ther. 2008;28:1140–1146.PubMedCrossRef
8.
go back to reference Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007;102:2627–2632.PubMedCrossRef Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007;102:2627–2632.PubMedCrossRef
9.
go back to reference Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801.PubMedCrossRef Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801.PubMedCrossRef
10.
go back to reference Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology or eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009;7:1055–1061.PubMedCrossRef Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology or eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009;7:1055–1061.PubMedCrossRef
11.
go back to reference Whitney-Miller CL, Katzka D, Furth EE. Eosinophilic esophagitis: a retrospective review of esophageal biopsy specimens from 1992 to 2004 at an adult academic medical center. Am J Clin Pathol. 2009;131:788–792.PubMedCrossRef Whitney-Miller CL, Katzka D, Furth EE. Eosinophilic esophagitis: a retrospective review of esophageal biopsy specimens from 1992 to 2004 at an adult academic medical center. Am J Clin Pathol. 2009;131:788–792.PubMedCrossRef
12.
go back to reference Vanderheyden AD, Petras RE, DeYoung BR, Mitros FA. Emerging eosinophilic (allergic) esophagitis: increased incidence or increased recognition. Arch Pathol Lab Med. 2007;131:777–779.PubMed Vanderheyden AD, Petras RE, DeYoung BR, Mitros FA. Emerging eosinophilic (allergic) esophagitis: increased incidence or increased recognition. Arch Pathol Lab Med. 2007;131:777–779.PubMed
13.
go back to reference Liacouras CA, Wenner WJ, Brown K, Buchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26:380–385.PubMedCrossRef Liacouras CA, Wenner WJ, Brown K, Buchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26:380–385.PubMedCrossRef
14.
go back to reference Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104:828–833.PubMedCrossRef Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104:828–833.PubMedCrossRef
15.
go back to reference Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6:531.PubMedCrossRef Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6:531.PubMedCrossRef
16.
go back to reference Mishra A, Hogan SP, Brandt EB, et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83–90.PubMedCrossRef Mishra A, Hogan SP, Brandt EB, et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83–90.PubMedCrossRef
17.
go back to reference Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol. 2007;41:451.PubMedCrossRef Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol. 2007;41:451.PubMedCrossRef
18.
go back to reference Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology. 2010;139:182.PubMedCrossRef Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology. 2010;139:182.PubMedCrossRef
19.
go back to reference Bullock JZ, Villanueva JM, Blanchard C, et al. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:22–31.PubMedCrossRef Bullock JZ, Villanueva JM, Blanchard C, et al. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:22–31.PubMedCrossRef
20.
go back to reference Frederickson NW, Lee YJ, Redd MK, Go J, Valestin J, Schey R. Lack of seasonal variation in the incidence of eosinophilic esophagitis (abstract). Gastroenterology. 2012;142:S437–S438. Frederickson NW, Lee YJ, Redd MK, Go J, Valestin J, Schey R. Lack of seasonal variation in the incidence of eosinophilic esophagitis (abstract). Gastroenterology. 2012;142:S437–S438.
21.
go back to reference Swoger JM, Weiler CR, Arora AS. Eosinophilic esophagitis: is it all allergies? Mayo Clin Proc. 2007;82:1541–1549.PubMedCrossRef Swoger JM, Weiler CR, Arora AS. Eosinophilic esophagitis: is it all allergies? Mayo Clin Proc. 2007;82:1541–1549.PubMedCrossRef
22.
go back to reference Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206.PubMedCrossRef Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206.PubMedCrossRef
23.
go back to reference Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011;9:110–117.PubMedCrossRef Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011;9:110–117.PubMedCrossRef
24.
go back to reference Shah A, Kagalwalla AF, Gonsalves N, Melin-Aldana H, Li BU, Hirano I. Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol. 2009;104:716–721.PubMedCrossRef Shah A, Kagalwalla AF, Gonsalves N, Melin-Aldana H, Li BU, Hirano I. Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol. 2009;104:716–721.PubMedCrossRef
25.
go back to reference Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.PubMedCrossRef Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.PubMedCrossRef
26.
go back to reference Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:435–442.PubMedCrossRef Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:435–442.PubMedCrossRef
27.
go back to reference Krarup AL, Villadsen GE, Mejlgaard E, Olesen SS, Drewes AM, Funch-Jensen P. Acid hypersensitivity in patients with eosinophilic eosophagitis. Scand J Gastroenterol. 2010;45:273–281.PubMedCrossRef Krarup AL, Villadsen GE, Mejlgaard E, Olesen SS, Drewes AM, Funch-Jensen P. Acid hypersensitivity in patients with eosinophilic eosophagitis. Scand J Gastroenterol. 2010;45:273–281.PubMedCrossRef
28.
go back to reference Zhang X, Cheng E, Huo X, et al. In esophageal squamous epithelial cell lines from patients with eosinophilic esophagitis (EoE), omeprazole blocks the stimulated secretion of eotaxin 3: a potential anti-inflammatory effect of omeprazole in EoE that is independent of acid inhibition. Gastroenterology. 2010;138:S-122.CrossRef Zhang X, Cheng E, Huo X, et al. In esophageal squamous epithelial cell lines from patients with eosinophilic esophagitis (EoE), omeprazole blocks the stimulated secretion of eotaxin 3: a potential anti-inflammatory effect of omeprazole in EoE that is independent of acid inhibition. Gastroenterology. 2010;138:S-122.CrossRef
29.
go back to reference Peterson KA, Thomas KL, Hilden K, et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci. 2010;55:1313–1319.PubMedCrossRef Peterson KA, Thomas KL, Hilden K, et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci. 2010;55:1313–1319.PubMedCrossRef
30.
go back to reference Dohil R, Newbury RO, Aceves S. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci. 2012;57:1413–1419.PubMedCrossRef Dohil R, Newbury RO, Aceves S. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci. 2012;57:1413–1419.PubMedCrossRef
31.
go back to reference Faubion WA Jr, Perrault J, Burgart LG, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27:90–93.PubMedCrossRef Faubion WA Jr, Perrault J, Burgart LG, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27:90–93.PubMedCrossRef
32.
go back to reference Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131:1381–1391.PubMedCrossRef Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131:1381–1391.PubMedCrossRef
33.
go back to reference Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526–1537.PubMedCrossRef Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526–1537.PubMedCrossRef
34.
go back to reference Aceves SS, Newbury RO, Chen D, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65:109–116.PubMedCrossRef Aceves SS, Newbury RO, Chen D, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65:109–116.PubMedCrossRef
35.
go back to reference Helou EF, Simonson J, Arora A. 3 Year-follow up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:2194–2199.PubMedCrossRef Helou EF, Simonson J, Arora A. 3 Year-follow up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:2194–2199.PubMedCrossRef
36.
go back to reference Schroeder S, Fleischer DM, Masterson JC, Gelfand E, Furuta GT, Atkins D. Successful treatment of eosinophilic esophagitis with ciclesonide. J Allergy Clin Immunol. 2012;129:1219–1221.CrossRef Schroeder S, Fleischer DM, Masterson JC, Gelfand E, Furuta GT, Atkins D. Successful treatment of eosinophilic esophagitis with ciclesonide. J Allergy Clin Immunol. 2012;129:1219–1221.CrossRef
37.
go back to reference Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol. 2008;6:165–173.PubMedCrossRef Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol. 2008;6:165–173.PubMedCrossRef
38.
go back to reference Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut. 2003;52:181–185.PubMedCrossRef Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut. 2003;52:181–185.PubMedCrossRef
39.
go back to reference Lucendo AJ, De Rezende LC, Jimenez-Contreras S, et al. Montelukast was inefficient in maintaining steroid induced remission in adult eosinophilic esophagitis. Dig Dis Sci. 2011;56:3551–3558.PubMedCrossRef Lucendo AJ, De Rezende LC, Jimenez-Contreras S, et al. Montelukast was inefficient in maintaining steroid induced remission in adult eosinophilic esophagitis. Dig Dis Sci. 2011;56:3551–3558.PubMedCrossRef
40.
go back to reference Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118:1312–1319.PubMedCrossRef Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118:1312–1319.PubMedCrossRef
41.
go back to reference Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic eosophagitus: a randomized, placebo-controlled, double-blind trial. Gut. 2010;59:21–30.PubMedCrossRef Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic eosophagitus: a randomized, placebo-controlled, double-blind trial. Gut. 2010;59:21–30.PubMedCrossRef
42.
go back to reference Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129:456–463.PubMedCrossRef Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129:456–463.PubMedCrossRef
43.
go back to reference Straumann A, Bussmann C, Conus S, Beglinger C, Simon HU. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol. 2008;122:425–427.PubMedCrossRef Straumann A, Bussmann C, Conus S, Beglinger C, Simon HU. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol. 2008;122:425–427.PubMedCrossRef
44.
go back to reference Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol. 2005;115:459–465.PubMedCrossRef Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol. 2005;115:459–465.PubMedCrossRef
45.
go back to reference Straumann A, Bussmann C, Perkins MC, et al. Treatment of eosinophilic esophagitis with the CRTH2-antagonist Oc000459: a novel therapeutic principle (abstract). Gastroenterology. 2012;142:S147. Straumann A, Bussmann C, Perkins MC, et al. Treatment of eosinophilic esophagitis with the CRTH2-antagonist Oc000459: a novel therapeutic principle (abstract). Gastroenterology. 2012;142:S147.
46.
go back to reference Kagalwalla AF, Sentongo TA, Ritz S, et al. LuBU: effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4:1097–1102.PubMedCrossRef Kagalwalla AF, Sentongo TA, Ritz S, et al. LuBU: effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4:1097–1102.PubMedCrossRef
47.
go back to reference Thompson JS, Lebwohl B, Reilly NR, Talley NJ, Bhaqat G, Green PH. Increased incidence of eosinophilic esophagitis in children and adults with celiac disease. J Clin Gastroenterol. 2012;36:e6–e11.CrossRef Thompson JS, Lebwohl B, Reilly NR, Talley NJ, Bhaqat G, Green PH. Increased incidence of eosinophilic esophagitis in children and adults with celiac disease. J Clin Gastroenterol. 2012;36:e6–e11.CrossRef
48.
go back to reference Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005;95:336–343.PubMedCrossRef Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005;95:336–343.PubMedCrossRef
49.
go back to reference Gonsalves N., Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142:1451–1459. Gonsalves N., Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142:1451–1459.
50.
go back to reference Hirano I. Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest Endosc. 2010;71:713–714.PubMedCrossRef Hirano I. Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest Endosc. 2010;71:713–714.PubMedCrossRef
51.
go back to reference Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011;73:14–21.CrossRef Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011;73:14–21.CrossRef
52.
go back to reference Dellon ES, Gibbs WB, Rubinas TC, et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc. 2010;71:706–712.PubMedCrossRef Dellon ES, Gibbs WB, Rubinas TC, et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc. 2010;71:706–712.PubMedCrossRef
Metadata
Title
Eosinophilic Esophagitis: Current Treatment
Authors
Matthew Redd
Ron Schey
Publication date
01-03-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2383-1

Other articles of this Issue 3/2013

Digestive Diseases and Sciences 3/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.